RT Journal Article
SR Electronic
T1 Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.12.19.22280175
DO 10.1101/2022.12.19.22280175
A1 Blauwendraat, Cornelis
A1 Tayebi, Nahid
A1 Woo, Elizabeth Geena
A1 Lopez, Grisel
A1 Fierro, Luca
A1 Toffoli, Marco
A1 Limbachiya, Naomi
A1 Hughes, Derralynn
A1 Pitz, Vanessa
A1 Patel, Dhairya
A1 Vitale, Dan
A1 Koretsky, Mathew J.
A1 Hernandez, Dena
A1 Real, Raquel
A1 Alcalay, Roy N.
A1 Nalls, Mike A
A1 Morris, Huw R
A1 Schapira, Anthony H. V.
A1 Balwani, Manisha
A1 Sidransky, Ellen
YR 2022
UL http://medrxiv.org/content/early/2022/12/20/2022.12.19.22280175.abstract
AB Background Bi-allelic pathogenic variants in GBA1 are the cause of Gaucher disease (GD1), a lysosomal storage disorder resulting from deficient glucocerebrosidase. Heterozygous GBA1 variants are also a common genetic risk factor for Parkinson’s disease (PD). GD manifests with considerable clinical heterogeneity and is also associated with an increased risk of PD.Objective To investigate the contribution of PD risk variants to risk of PD in patients with GD1.Methods We studied 225 patients with GD1, including 199 without PD and 26 with PD. All cases were genotyped and the genetic data was imputed using common pipelines.Results On average, patients with GD1 with PD have a significantly higher PD genetic risk score than those without PD (P=0.021).Conclusions Our results indicate that variants included in the PD genetic risk score were more frequent in patients with GD1 who developed PD, suggesting that common risk variants may affect underlying biological pathways.Supplemental data hereCompeting Interest StatementFinancial Disclosures M.A.N. and D.V. are consultants employed by Data Tecnica International, whose participation in this is part of a consulting agreement between the US National Institutes of Health and said company. Funding StatementThis work was supported in part by the Intramural Research Program of the National Human Genome Research Institute (NHGRI), the Center for Alzheimer`s and Related Dementias, within the Intramural Research Program of the National Institute on Aging and the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services, and the National Institutes of Health and Cure Parkinson`s (UK).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Each contributing study abided by the ethics guidelines set out by their institutional review boards, and all participants gave informed consent for inclusion in both their initial cohorts and subsequent studies. The research of these cohorts was deemed not human subjects research by the NIH Office of IRB Operations which stated that no IRB approval is required. Data used in the preparation of this article were obtained from Global Parkinson`s Genetics Program (GP2, http://gp2.org/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript. https://github.com/GP2code/Neuro_Booster_Array https://amp-pd.org/